CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-05-04 | Hanley Rochelle Chief Medical Officer | Grant or award | +70,000 | 161,547 | ||
| 2015-05-04 | Hanley Rochelle Chief Medical Officer | Shares withheld for taxes | +7,308 | $9.49 | $69K | 168,855 |
| 2015-05-04 | Hanley Rochelle Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2015-05-04 | FOEHR MATTHEW W Director | Purchase | +6,250 | $8.00 | $50K | 6,250 |
| 2015-04-28 | Webster Stephen W Director | Grant or award · Stock Option (Right to Buy) | +20,786 | 20,786 | ||
| 2015-04-28 | MACARTNEY LAWSON Director | Grant or award · Stock Option (Right to Buy) | +20,786 | 20,786 | ||
| 2015-04-28 | FOEHR MATTHEW W Director | Grant or award · Stock Option (Right to Buy) | +20,786 | 20,786 | ||
| 2015-04-28 | SINGLETON J MATTHEW Director | Grant or award · Stock Option (Right to Buy) | +20,786 | 20,786 |
Page 27 of 27 · 528 trades